Percutaneous pericardiocentesis followed by pericardiodesis and systemic chemotherapy can effectively control malignant pericardial effusion and prolong life in patients with recurrent breast cancer.
May support pericardiocentesis and pericardiodesis for tamponade control in recurrent breast cancer; hypothesis-generating case series leaves open prospective validation.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Ue et al. (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: